|Market Cap (Intraday)||22.31M|
|2yr Forward PE||N/A|
iSpecimen Inc Stock, NASDAQ:ISPC
iSpecimen, Inc. operates as healthcare organization that engages in procurement of human biospecimens. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in July 2009 and is headquartered in Lexington, MA.